| American academy of neurology annual meeting. | |
| | |
MedLine Citation:
|
PMID: 21689501 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The American Academy of Neurology (AAN) Annual Meeting was held in Toronto, Canada from 10 to 17 April, 2010. As usual, multiple sclerosis (MS) featured prominently with about 450 poster and platform presentations on various aspects. Highlights were presentations on the controversial theory of venous obstruction as a cause of MS and updates on promising oral treatments, particularly fingolimod, cladribine and teriflumomide. |
| | |
Authors:
|
Ernest Willoughby |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: International MS journal / MS Forum Volume: 17 ISSN: 1352-8963 ISO Abbreviation: Int MS J Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-06-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9804403 Medline TA: Int MS J Country: England |
Other Details:
|
Languages: eng Pagination: 69-70 Citation Subset: IM |
Affiliation:
|
Auckland, New Zealand. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tumour Necrosis Factor Neutralization in MS: A Cautionary Tale.
Next Document: Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unres...